A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy.

Peper, Janet Kerstin; Stevanovic, Stefan

Peper, Janet Kerstin; Stevanovic, Stefan.

Affiliation

Peper JK; Department of Immunology, Institute of Cell Biology, University of Tübingen, Auf der Morgenstelle 15, 72076, Tübingen, Germany, janet-peper@gmx.de.

Cancer Immunol Immunother ; 64(10): 1295-303, 2015 Oct.

Article in En | MEDLINE | ID: mdl-25822767

Subject(s)

Immunotherapy/methods; Ovarian Neoplasms/therapy; Vaccines, Subunit; Animals; Antigens, Neoplasm/metabolism; Clinical Trials as Topic; Female; HLA Antigens/metabolism; Humans; Immunotherapy/trends; Ligands; Molecular Targeted Therapy; Ovarian Neoplasms/immunology; Peptide Fragments/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Vaccines, Subunit / Immunotherapy Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2015 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google